Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical sector. Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most MNC pharma companies, leading CROs, investment banks, consulting firms active in China as well as relevant industry associations and government agencies.

Note: To view full text of free articles, you need to register as a basic member first and then log in. To view premium articles, you need to subscribe to Pharma China as a premium member. For more information or subscription, please contact info@pharmachinaonline.com. If you wish to unsubscribe from this e-Alert, please reply this e-mail with "Remove" in the subject line.
The Market
NH's DB6: Top Ten Chinese OTC Brands in 2019(4/10/2020 )  (Premium)
Asia Pacific Drug Delivery Systems Market Has Promising Opportunities 2020-2027(4/10/2020 )  (Premium)
Asia Pacific and Chinese CRO Market Value Projected to Expand By 2025(4/9/2020 )  (Premium)
Nicholas Hall's Review of China's OTC Drug Market Performance 2019(4/9/2020 )  (Premium)
Industry News
Boehringer Ingelheim Biopharmaceuticals China Receives ¡°ISPE Facility of the Year¡± Award(4/9/2020 )  (free)
Regeneron and Zai Lab Announce Regional Strategic Collaboration for REGN1979(4/8/2020 )  (Premium)
GenScript ProBio and Eutilex Partner to Develop Anti-cancer Immunotherapy Technology(4/8/2020 )  (Premium)
Immutep and EOC Continue to Advance Breast Cancer Drug Efti in China(4/7/2020 )  (Premium)
GSK and Innovax in Partnership for COVID-19 Vaccine R&D(4/7/2020 )  (Premium)
Akeso Biotech Sets $300M IPO in Motion(4/7/2020 )  (Premium)
Regulatory News
CDE Solicits Public Comments for Clinical Research Guidelines for Bevacizumab Biosimilars(4/10/2020 )  (Premium)
CDE Solicits Public Comments for Clinical Research Guidelines for Trastuzumab Biosimilars(4/7/2020 )  (Premium)
CDE Solicits Public Comments for Clinical Research Guidelines for Bevacizumab Biosimilars(4/7/2020 )  (Premium)
General Health
Infectious Diseases in Children and Adolescents in China: Analysis of National Surveillance Data from 2008 to 2017(4/9/2020 )  (Premium)
Product/R&D News
China Recruits Volunteers for Phase 2 Coronavirus Vaccine Trial(4/9/2020 )  (Premium)
API/Bulk Drug News
India Lifts Export Restrictions on 24 APIs(4/7/2020 )  (Premium)
© Wicon International Group¡¡Support by: www.heightow.com Home | Site map | Contact Us | Links